Table 4.
Bivariate analysis of medications associated with new-onset insomnia among hospitalised patients without a prior history of insomnia at a tertiary care centre in Lebanon (N = 75)
| Medication taken | Hospitalised patients, n (%) | P value | |
|---|---|---|---|
| Without new-onset insomnia (n = 9) | With new-onset insomnia* (n = 66) | ||
| Corticosteroids | 1 | ||
| No | 8 (12.9) | 54 (87.1) | |
| Yes | 1 (7.7) | 12 (92.3) | |
| Levothyroxine | 1 | ||
| No | 9 (12.5) | 63 (87.5) | |
| Yes | 0 (0) | 3 (100.0) | |
| Proton pump inhibitors | 0.720 | ||
| No | 5 (10.6) | 42 (89.4) | |
| Yes | 4 (14.3) | 24 (85.7) | |
| Anti-viral medications | 1 | ||
| No | 9 (12.9) | 61 (87.1) | |
| Yes | 0 (0) | 5 (100.0) | |
| Carbapenems | 0.549 | ||
| No | 8 (11.6) | 61 (88.4) | |
| Yes | 1 (16.7) | 5 (83.3) | |
| Cephalosporins | 0.674 | ||
| No | 8 (13.8) | 50 (86.2) | |
| Yes | 1 (5.9) | 16 (94.1) | |
| Paracetamol | 1 | ||
| No | 8 (13.1) | 53 (86.9) | |
| Yes | 1 (7.1) | 13 (92.9) | |
| Non-steroidal anti-inflammatory drugs | 0.588 | ||
| No | 9 (13.6) | 57 (86.4) | |
| Yes | 0 (0) | 9 (100.0) | |
| Beta-blockers | 0.344 | ||
| No | 7 (10.8) | 58 (89.2) | |
| Yes | 2 (20.0) | 8 (80.0) | |
| Diuretics | 0.294 | ||
| No | 7 (10.6) | 59 (89.4) | |
| Yes | 2 (22.2) | 7 (77.8) | |
| Pregabalin | 1 | ||
| No | 9 (12.7) | 62 (87.3) | |
| Yes | 0 (0) | 4 (100.0) | |
| Anti-spasmodic drugs | 1 | ||
| No | 9 (12.5) | 63 (87.5) | |
| Yes | 0 (0) | 3 (100.0) | |
| Statins | 1 | ||
| No | 9 (12.5) | 63 (87.5) | |
| Yes | 0 (0) | 3 (100.0) | |
| Anti-emetic drugs | 1 | ||
| No | 9 (12.7) | 62 (87.3) | |
| Yes | 0 (0) | 4 (100.0) | |
| Quinolones | 0.227 | ||
| No | 8 (11.0) | 65 (89.0) | |
| Yes | 1 (50.0) | 1 (50.0) | |
| Bronchodilators | 1 | ||
| No | 9 (12.9) | 61 (87.1) | |
| Yes | 0 (0) | 5 (100.0) | |
| Allopurinol | 1 | ||
| No | 9 (12.3) | 64 (87.7) | |
| Yes | 0 (0) | 2 (100.0) | |